Drugs / Flucelvax Quad
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06125691 Comparator | Jan → Aug 2024 | influenza | Arcturus Therapeutics, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT05223179 Comparator | Apr 2022 → Feb 2024 | influenza | Codagenix, Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flucelvax Quad | “For younger adults: Flucelvax® Quad, Seqirus Pty Ltd.” NCT06125691 ↗ |
| Modality | Vaccine | “Licensed Seasonal Injectable Influenza Vaccine” NCT05223179 ↗ |